Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma
Cancer Immunotherapy: 2016 vs 2026
Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04
10 Must-Read Posts In GU Oncology This Week
Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC
ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month
Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer
The CDDF & EORTC Joint Workshop on Health Technology Assessment in Cancer Drug Development will take place on October 5–6, 2026, at the Cardo Hotel Brussels in Brussels, Belgium, with online participation available. Jointly organized by the Cancer Drug Development Forum (CDDF) and European Organisation for Research and Treatment of Cancer (EORTC), the workshop will […]
